Peripherally induced RORγt<sup>+</sup> skin-resident regulatory T cells mediate the efficacy of allergen-specific immunotherapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40435216.
- Also identified by DOI 10.1126/scitranslmed.ado1375.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Skin-resident regulatory T cells (T<sub>reg</sub> cells) cells play a critical role in subcutaneous allergen-specific immunotherapy (SIT) for atopic dermatitis (AD). However, a detailed description of the phenotype and origin of skin-resident T<sub>reg</sub> cells during SIT is lacking. Therefore, we investigated the role and origin of specific T<sub>reg</sub> lineages in SIT with human AD samples and with a mouse model of AD. In the blood of patients with AD who responded to SIT, T<sub>reg</sub> cells showed a notable increase in retinoic acid-related orphan receptor γt (RORγt) expression. Moreover, RORγt-expressing T<sub>reg</sub> cells expanded in the skin of patients with AD upon SIT. In a mouse model of AD, the absence of RORγt expression in skin T<sub>reg</sub> cells led to reduced therapeutic efficacy with SIT. In addition, SIT-induced RORγt<sup>+</sup> T<sub>reg</sub> cells originated from peripheral tissue rather than from the thymus. Using two-photon microscopy and a parabiosis mouse model, we observed the migration and accumulation of skin-resident RORγt<sup>+</sup> T<sub>reg</sub> cells in response to the SIT-induced immune response. These findings indicate that SIT induces peripheral RORγt<sup>+</sup> T<sub>reg</sub> cell expansion, which contributes to the therapeutic efficacy of SIT.
Medical subject headings
- Nuclear Receptor Subfamily 1, Group F, Member 3
- T-Lymphocytes, Regulatory
- Skin
- Allergens
- Desensitization, Immunologic